Health Care & Life Sciences » Healthcare Provision | Venn Life Sciences Holdings PLC

Venn Life Sciences Holdings PLC | Cash Flow

Fiscal year is January-December. All values GBP Thousands.
2013
2014
2015
2016
2017
Net Income before Extraordinaries
1,548.40
1,473.40
237.30
748.50
1,458.30
Depreciation, Depletion & Amortization
27.20
150.60
336.80
673.90
756.70
Other Funds
-
520.40
225.00
12.30
-
Funds from Operations
1,473.60
1,272.80
224.30
906.70
141.00
Changes in Working Capital
95.10
451.90
1,784.80
1,045.30
1,037.90
Net Operating Cash Flow
1,568.80
820.90
1,560.50
138.60
1,178.90
Capital Expenditures
26.30
79.80
517.50
-
455.40
Sale of Fixed Assets & Businesses
-
4.00
-
-
-
Purchase/Sale of Investments
-
-
-
-
407.30
Net Investing Cash Flow
72.20
323.00
2,043.20
64.80
862.70
Issuance/Reduction of Debt, Net
276.00
124.90
68.20
22.10
30.70
Net Financing Cash Flow
276.00
1,357.40
5,927.80
9.80
30.70
Net Change in Cash
1,983.20
213.50
2,324.10
210.70
2,072.30
Free Cash Flow
1,595.10
900.70
2,078.00
138.60
1,347.90
Net Assets from Acquisitions
45.90
247.30
1,374.00
-
-
Change in Capital Stock
-
961.90
6,221.10
-
-
Exchange Rate Effect
66.30
-
-
2.50
-
Other Uses
-
-
151.70
64.80
-

About Venn Life Sciences Holdings

View Profile
Address
19 Railway Road
Dublin Dublin
Ireland
Employees -
Website http://www.vennlifesciences.com
Updated 09/14/2018
Venn Life Sciences Holdings Plc is a clinical research organization, which provides a suite of consulting and clinical trial services to pharmaceutical, biotechnology, and medical device organizations. Its services include drug development planning and strategy, early drug development, clinical monitoring, medical monitoring, investigator initiated studies, clinical feasibility assessment, regulatory affairs and consulting, quality assurance, and drug development training and courses. The company is headquartered in Dublin, Ireland.